These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16826487

  • 1. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
    Kim SH, Bang JW, Park KH, Park WB, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.
    J Infect Dis; 2006 Aug 01; 194(3):377-84. PubMed ID: 16826487
    [Abstract] [Full Text] [Related]

  • 2. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E, Smetana Z, Tanay A, Dalal I, Babai I, Mendelson E.
    Vaccine; 2004 Dec 02; 23(3):321-4. PubMed ID: 15530675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.
    Clin Microbiol Infect; 2007 Jan 02; 13(1):91-3. PubMed ID: 17184294
    [Abstract] [Full Text] [Related]

  • 5. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J, Wu H, Liang H, Topham DJ.
    Vaccine; 2006 Nov 17; 24(47-48):6913-23. PubMed ID: 17014939
    [Abstract] [Full Text] [Related]

  • 6. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
    Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R.
    J Clin Virol; 2007 Sep 17; 40(1):80-3. PubMed ID: 17644471
    [Abstract] [Full Text] [Related]

  • 7. Persistence of cell-mediated immunity to vaccinia virus.
    Kim SH, Oh MD.
    J Infect Dis; 2007 Sep 01; 196(5):805-6. PubMed ID: 17674329
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immune responses to smallpox vaccination.
    Kim SH, Yeo SG, Cho JH, Kim HB, Kim NJ, Oh MD, Choe KW, Jee Y, Cho H.
    Clin Vaccine Immunol; 2006 Oct 01; 13(10):1172-4. PubMed ID: 17028221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
    Ennis FA, Cruz J, Demkowicz WE, Rothman AL, McClain DJ.
    J Infect Dis; 2002 Jun 01; 185(11):1657-9. PubMed ID: 12023773
    [Abstract] [Full Text] [Related]

  • 11. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, Hsu KH.
    Vaccine; 2006 Jan 23; 24(4):510-5. PubMed ID: 16139395
    [Abstract] [Full Text] [Related]

  • 12. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
    Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.
    J Infect Dis; 2004 Oct 01; 190(7):1286-94. PubMed ID: 15346340
    [Abstract] [Full Text] [Related]

  • 13. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.
    Vaccine; 2015 Jun 12; 33(26):2990-6. PubMed ID: 25930115
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.
    Wiser I, Orr N, Kaufman B, Segev S, Smetana Z, Bialik A, Epstein N, Mendelson E, Catane R, Cohen D.
    J Infect Dis; 2010 May 15; 201(10):1527-34. PubMed ID: 20388035
    [Abstract] [Full Text] [Related]

  • 15. Dose-dependent neutralizing-antibody responses to vaccinia.
    Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L.
    J Infect Dis; 2004 Feb 01; 189(3):493-7. PubMed ID: 14745707
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
    Bricaire F, Combadière B, Rouleau E, Bossi P, Garin D, Lebrun-Vignes B, Autran B.
    Bull Acad Natl Med; 2006 Feb 01; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
    [Abstract] [Full Text] [Related]

  • 17. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G.
    J Infect Dis; 2009 Jan 01; 199(1):39-48. PubMed ID: 19012492
    [Abstract] [Full Text] [Related]

  • 18. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
    Borges MB, Kato SE, Damaso CR, Moussatché N, da Silva Freire M, Lambert Passos SR, do Nascimento JP.
    Biologicals; 2008 Mar 01; 36(2):105-10. PubMed ID: 17892944
    [Abstract] [Full Text] [Related]

  • 19. [Examinations for smallpox allergy with the aid of a modified skin test (author's transl)].
    Ambrosch F, Stemberger H, Kundi M, Wiedermann G.
    Zentralbl Bakteriol Orig A; 1978 Jun 01; 240(4):431-40. PubMed ID: 696056
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
    Frey SE, Newman FK, Kennedy JS, Ennis F, Abate G, Hoft DF, Monath TP.
    Vaccine; 2009 Mar 04; 27(10):1637-44. PubMed ID: 19071184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.